Showing results (1361-1370 of 1,406) with videos related to
Sort By:
Pageof 141
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 9, 2005
[Study on the current situation and influential factors of child neglect among aged 3-6 year-olds in the urban areas of China]Jian-ping Pan, Zi-ni Yang, Xu-hong Ren, et al.Nature Communications|March 31, 2023
Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotypeXin-Hua Wu, Yang-Yang He, Zhang-Rong Chen, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis BRui Yu, Deming Tan, Qin Ning, et al.Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 26, 2007
[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]Ji-dong Jia, Jin-lin Hou, You-kuan Yin, et al.Risk Management and Healthcare Policy|April 1, 2021
Impact of Prior Digestive System Disease on In-Hospital Gastrointestinal Bleeding in Patients with Acute Myocardial InfarctionYu Liu, Le-Feng Wang, Li-Hong Liu, et al.Advances in Therapy|July 12, 2025
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 TrialYan Zhao, Litao Zhang, Liming Wu, et al.Hepatology (Baltimore, Md.)|January 3, 2014
The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled studyJian Sun, Qing Xie, Deming Tan, et al.The Journal of Dermatological Treatment|July 6, 2026
Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trialYan Zhao, Litao Zhang, Liming Wu, et al.Journal of Clinical and Translational Hepatology|March 27, 2018
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch StudyPeng Hu, Jia Shang, Wenhong Zhang, et al.Dermatitis : Contact, Atopic, Occupational, Drug|March 28, 2025
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic DermatitisYan Zhao, Litao Zhang, Liming Wu, et al.Pageof 141